Tower Research Capital LLC (Trc) Dr Reddys Laboratories LTD Transaction History

Tower Research Capital LLC (Trc)

$5.8 Billion
Q2 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$67.36 - $77.59 $16,166 - $18,621	-240 Reduced 52.4%	218 $15,000
Q4 2023 Feb 13, 2024	SELL	$64.27 - $69.9 $95,698 - $104,081	-1,489 Reduced 76.48%	458 $31,000
Q3 2023 Nov 14, 2023	BUY	$61.9 - $72.77 $117,114 - $137,680	1,892 Added 3440.0%	1,947 $130,000
Q2 2023 Aug 14, 2023	SELL	$53.34 - $63.11 $206,745 - $244,614	-3,876 Reduced 98.6%	55 $3,000
Q1 2023 May 09, 2023	BUY	$51.63 - $56.93 $183,234 - $202,044	3,549 Added 929.06%	3,931 $223,000
Q4 2022 Feb 10, 2023	BUY	$51.15 - $57.45 $1,483 - $1,666	29 Added 8.22%	382 $20,000
Q3 2022 Nov 10, 2022	SELL	$49.9 - $57.32 $18,413 - $21,151	-369 Reduced 51.11%	353 $18,000
Q2 2022 Aug 15, 2022	SELL	$49.62 - $58.13 $58,750 - $68,825	-1,184 Reduced 62.12%	722 $40,000
Q1 2022 May 12, 2022	BUY	$48.27 - $65.25 $88,092 - $119,081	1,825 Added 2253.09%	1,906 $106,000
Q4 2021 Feb 14, 2022	SELL	$59.5 - $67.25 $5,295 - $5,985	-89 Reduced 52.35%	81 $5,000
Q3 2021 Nov 15, 2021	SELL	$60.19 - $75.29 $265,799 - $332,480	-4,416 Reduced 96.29%	170 $11,000
Q2 2021 Aug 16, 2021	BUY	$62.12 - $74.2 $117,655 - $140,534	1,894 Added 70.36%	4,586 $337,000
Q1 2021 May 17, 2021	BUY	$57.98 - $73.08 $19,017 - $23,970	328 Added 13.87%	2,692 $165,000
Q4 2020 Feb 16, 2021	SELL	$62.61 - $71.29 $145,443 - $165,606	-2,323 Reduced 49.56%	2,364 $169,000
Q3 2020 Nov 16, 2020	BUY	$51.39 - $72.41 $240,864 - $339,385	4,687 New	4,687 $326,000
Q2 2020 Aug 13, 2020	SELL	$39.55 - $54.65 $290,297 - $401,131	-7,340 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$34.75 - $45.85 $13,378 - $17,652	-385 Reduced 4.98%	7,340 $296,000
Q4 2019 Feb 07, 2020	BUY	$36.66 - $41.78 $269,487 - $307,124	7,351 Added 1965.51%	7,725 $313,000
Q3 2019 Nov 05, 2019	SELL	$34.82 - $39.26 $238,029 - $268,381	-6,836 Reduced 94.81%	374 $14,000
Q2 2019 Aug 13, 2019	BUY	$36.05 - $42.76 $259,920 - $308,299	7,210 New	7,210 $270,000
Q1 2019 May 14, 2019	SELL	$35.77 - $40.57 $56,123 - $63,654	-1,569 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$31.89 - $38.44 $34,696 - $41,822	-1,088 Reduced 40.95%	1,569 $59,000
Q3 2018 Nov 13, 2018	SELL	$29.25 - $36.73 $559,084 - $702,057	-19,114 Reduced 87.8%	2,657 $92,000
Q2 2018 Aug 15, 2018	BUY	$28.49 - $35.06 $616,181 - $758,277	21,628 Added 15124.48%	21,771 $701,000
Q1 2018 May 15, 2018	BUY	$31.93 - $39.54 $4,565 - $5,654	143 New	143 $5,000
Q4 2017 Feb 09, 2018	SELL	$34.15 - $37.62 $83,838 - $92,357	-2,455 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$30.11 - $37.72 $73,920 - $92,602	2,455	2,455 $88,000

Others Institutions Holding RDY

# of Institutions

233

Shares Held

24M

Call Options Held

14.6K

Put Options Held

2.8K

Robeco Institutional Asset Management B.V.

2.07M
Shares

$164 Million
0.34% of portfolio
Royal Bank Of Canada Toronto, A6

2.06M
Shares

$163 Million
0.04% of portfolio
Morgan Stanley New York, NY

2.03M
Shares

$161 Million
0.01% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

2M
Shares

$159 Million
0.27% of portfolio
Black Rock Inc. New York, NY

1.8M
Shares

$143 Million
0.0% of portfolio

View Full List

About DR REDDYS LABORATORIES LTD

Ticker RDY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 166,028,992
Market Cap $13.2B
Description
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...

More about RDY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account